Why the study?
Do oral rotavirus vaccines provide safety, immunogenicity, and efficacy against rotavirus gastroenteritis in infants?
Do oral rotavirus vaccines provide safety, immunogenicity, and efficacy against rotavirus gastroenteritis in infants?
Oral rotavirus vaccines demonstrate dose-dependent immunogenicity and up to 75% protective efficacy against rotavirus gastroenteritis in infants, with better protection against severe disease.
No takes yet. Share an insight, caveat, or question.
Supports rotavirus vaccination strategies in infants; leaves open confirmation via contemporary randomized trials.
Vesikari et al. (1996) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: